This Biotech’s Mission Is To Go Global – And Revolutionize Cancer Treatment
“We have a $5 billion market cap now. The next stage is for us to get to $20 billion,” declares the chief executive of the…
Cancer Treatment
These 3 Biotech Stocks May Be The Best Pure Plays On Two Remarkable Advances In Cancer Treatment
A number of conferences have recently taken place where cancer researchers have revealed the latest and most promising developments in the fight against this disease.…